Get the Stockscreener App
197.60
2.52%
-5.11
After Hours:
198.00
0.40
+0.20%
Overview
News
Price History
Option Chain
Financials
Why EFX Down?
Discussions
Forecast
Stock Split
Dividend History
Equifax Inc stock is traded at $197.60, with a volume of 2.83M.
It is down -2.52% in the last 24 hours and down -12.94% over the past month.
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates about 20%-25% of its revenue from outside the United States.
See More
Previous Close:
$202.71
Open:
$199.87
24h Volume:
2.83M
Relative Volume:
1.66
Market Cap:
$23.79B
Revenue:
$5.94B
Net Income/Loss:
$661.30M
P/E Ratio:
37.45
EPS:
5.2762
Net Cash Flow:
$999.40M
1W Performance:
+9.15%
1M Performance:
-12.94%
6M Performance:
-17.54%
1Y Performance:
-21.90%
1-Day Range:
$192.41
$201.00
1-Week Range:
$180.72
$203.88
52-Week Range:
$166.02
$281.03
Equifax Inc Stock (EFX) Company Profile
Name
Equifax Inc
Sector
Industry
Phone
(404) 885-8000
Address
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
197.60 | 24.41B | 5.94B | 661.30M | 999.40M | 5.2762 |
|
VRSK
Verisk Analytics Inc
|
173.77 | 23.62B | 3.03B | 914.60M | 1.12B | 6.5505 |
|
BAH
Booz Allen Hamilton Holding Corp
|
79.79 | 10.85B | 11.78B | 870.25M | 844.17M | 6.70 |
|
FCN
Fti Consulting Inc
|
156.81 | 5.35B | 3.73B | 312.01M | 434.78M | 8.70 |
|
HURN
Huron Consulting Group Inc
|
131.11 | 2.51B | 1.47B | 85.47M | 106.27M | 4.60 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Oppenheimer | Outperform |
| Oct-01-25 | Initiated | Seaport Research Partners | Neutral |
| Jul-10-25 | Initiated | BMO Capital Markets | Market Perform |
| Jun-23-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-10-25 | Resumed | BofA Securities | Buy |
| Apr-04-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-20-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-14-25 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Feb-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-16-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-12-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-12-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-01-24 | Initiated | UBS | Buy |
| Sep-19-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Aug-13-24 | Initiated | Wells Fargo | Overweight |
| Jul-09-24 | Initiated | Wolfe Research | Outperform |
| Feb-13-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-11-24 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Jan-08-24 | Upgrade | BofA Securities | Underperform → Buy |
| Jan-04-24 | Reiterated | Needham | Buy |
| Dec-19-23 | Initiated | Oppenheimer | Outperform |
| Dec-18-23 | Upgrade | Jefferies | Hold → Buy |
| Dec-15-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-08-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-20-23 | Initiated | Citigroup | Buy |
| Jul-24-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Initiated | Exane BNP Paribas | Underperform |
| Nov-15-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-21-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-19-22 | Downgrade | Jefferies | Buy → Hold |
| Aug-16-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-15-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-13-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-21-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-30-22 | Initiated | Deutsche Bank | Hold |
| Mar-11-22 | Resumed | BofA Securities | Neutral |
| Jan-31-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-27-22 | Upgrade | Truist | Hold → Buy |
| Jan-24-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-05-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-22-21 | Upgrade | Argus | Hold → Buy |
| Oct-15-21 | Resumed | Evercore ISI | Outperform |
| Jul-23-21 | Reiterated | Goldman | Neutral |
| Jul-08-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-15-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Dec-11-20 | Upgrade | Stifel | Hold → Buy |
| Dec-08-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-07-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-06-20 | Initiated | Needham | Buy |
| Jul-10-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jun-09-20 | Downgrade | SunTrust | Buy → Hold |
| May-15-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-06-20 | Downgrade | Argus | Buy → Hold |
| Mar-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-02-20 | Upgrade | Exane BNP Paribas | Underperform → Outperform |
| Jan-17-20 | Upgrade | Argus | Hold → Buy |
| Nov-22-19 | Initiated | Jefferies | Buy |
| Mar-15-19 | Initiated | Exane BNP Paribas | Underperform |
| Feb-05-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-07-18 | Resumed | Credit Suisse | Outperform |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Oct-23-18 | Resumed | BofA/Merrill | Underperform |
| Apr-10-18 | Initiated | BofA/Merrill | Underperform |
| Dec-14-17 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Equifax Inc Stock (EFX) Latest News
Equifax (EFX) Valuation Check After Earnings Beat, 2026 Outlook, Buybacks And New Growth Initiatives - simplywall.st
Here's Why You Should Hold Equifax Stock in Your Portfolio Now - Yahoo Finance
Equifax's Q4 Earnings Call: Our Top 5 Analyst Questions - Finviz
Madison Asset Management LLC Increases Stock Position in Equifax, Inc. $EFX - MarketBeat
Equifax, Inc. $EFX Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat
Why (EFX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
19,038 Shares in Equifax, Inc. $EFX Purchased by Katamaran Capital LLP - MarketBeat
Equifax’s Q4 Earnings Call: Our Top 5 Analyst Questions - The Globe and Mail
EFX Price Target Lowered to $208 by Goldman Sachs | EFX Stock Ne - GuruFocus
Equifax (EFX) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Needham & Company LLC Lifts Earnings Estimates for Equifax - MarketBeat
Equifax accused of price gouging Medicaid programs - WSAW
Gen Digital Links AI Agent Security With Equifax Powered Consumer Protection - Yahoo Finance
Equifax Inc. (EFX) Unveils Credit Card Origination and Employment Insight Solutions - Finviz
Envestnet Asset Management Inc. Raises Stake in Equifax, Inc. $EFX - MarketBeat
Equifax’s AI Push, Cloud Shift And Buybacks Might Change The Case For Investing In EFX - simplywall.st
Equifax providing a new six-year credit-monitoring service to victims of 2017 data breach - WGAL
Gen Digital, Equifax Partner To Offer Tools For Managing Finances And Online Security - Crowdfund Insider
Equifax Fell 6% Last Week. Here’s Where the Stock Could Head in 2026 - TIKR.com
Goldman Sachs Adjusts Equifax Price Target to $208 From $235, Maintains Neutral Rating - marketscreener.com
Equifax Announces Earnings Release Date and Conference Call for Fourth Quarter 2025 Results - Eastern Progress
Research Alert: CFRA Lowers Rating On Shares Of Equifax Inc. To Hold From Buy - 富途牛牛
Senators accuse Equifax of price gouging - KVUE
JPMorgan Chase & Co. Has Lowered Expectations for Equifax (NYSE:EFX) Stock Price - MarketBeat
JP Morgan Lowers Price Target for EFX, Maintains Overweight Rati - GuruFocus
EFX: Stifel Maintains Buy Rating, Lowers Price Target to $235 | - GuruFocus
Senators investigate Equifax's role in Medicaid verification - NonStop Local KHQ
Royal Bank Of Canada Issues Pessimistic Forecast for Equifax (NYSE:EFX) Stock Price - MarketBeat
Equifax (EFX) Valuation Reassessed After Recent Share Price Pullback - Yahoo Finance
Equifax (EFX) Maintains Equal-Weight, Price Target Lowered by Ba - GuruFocus
EFX: RBC Capital Maintains Rating and Lowers Price Target | EFX Stock News - GuruFocus
Senators Accuse Equifax of ‘Price-Gouging’ Medicaid Programs - The New York Times
Getting a new Bilt or Apple Card soon? How to maximize your credit score during a transition - CNBC
EFX Analyst Update: Morgan Stanley Lowers Price Target to $244 | - GuruFocus
EFX: Wells Fargo Lowers Price Target but Maintains Overweight Ra - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Equifax (NYSE:EFX) Stock Price - MarketBeat
Wells Fargo Adjusts Price Target on Equifax to $240 From $265, Maintains Overweight Rating - marketscreener.com
Baird Adjusts Price Target on Equifax to $250 From $289, Maintains Outperform Rating - marketscreener.com
These Analysts Cut Their Forecasts On Equifax After Q4 Earnings - Benzinga
Barclays Adjusts Price Target on Equifax to $215 From $240, Maintains Equalweight Rating - marketscreener.com
JPMorgan Adjusts Price Target on Equifax to $230 From $260, Maintains Overweight Rating - marketscreener.com
Equifax (EFX) Faces Target Price Adjustment Amidst Maintained Bu - GuruFocus
RBC Cuts Price Target on Equifax to $222 From $250, Keeps Outperform Rating - marketscreener.com
Needham & Company LLC Lowers Equifax (NYSE:EFX) Price Target to $265.00 - MarketBeat
Equifax Inc. (NYSE: EFX) Q4 2025 earnings call transcript - MSN
Equifax Inc. (NYSE:EFX) Q4 2025 Earnings Call Transcript - Insider Monkey
Senators Demand Answers on Equifax Plan to 'Profiteer' Off GOP Medicaid Work Requirements - Common Dreams
Breaking Down Equifax: 5 Analysts Share Their Views - Benzinga
Equifax: Resilient Data Moat and FICO-Driven Upside Undervalued, Supporting Buy Rating - TipRanks
Morgan Stanley Lowers Price Target on Equifax to $244 From $269, Keeps Overweight Rating - marketscreener.com
Equifax (NYSE:EFX) Sets New 1-Year LowWhat's Next? - MarketBeat
Equifax Inc Stock (EFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.54%
11.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):